Patient characteristics | Univariate OR (95%CI) | P | Multivariate OR (95%CI) | P |
---|---|---|---|---|
Age | 1.0 (1.0–1.1) | 0.078* | ||
Gender | ||||
-Female -Male | 1 1.1 (0.5–2.7) | 0.784 | ||
GFI | ||||
-<= 3 ->3 | 1 1.4 (0.5–3.9) | 0.525 | ||
MMSE | ||||
->26 -<= 26 | 1 7.1 (2.4–21.3) | < 0.001 | 1 8.9 (2.8–27.9) | < 0.001 |
CCS | ||||
-<= 2 ->2 | 1 1.1 (0.4-3.0) | 0.046* | ||
Highest Postoperative complication (ClavienDindo without delirium and death) | ||||
-No complication -Grade I -Grade II -Grade III -Grade IV | 1 0.6 (0.1–4.9) 1.3 (0.4–3.7) 1.2 (0.2–5.8) 9.3 (2.0–43.0) | 0.061* | ||
Anaesthesia-related factors | ||||
Type anesthesia | ||||
-General -Combined general and neuraxial anaesthesia | 1 1.2 (0.5–2.9) | 0.685 | ||
Duration of anaesthesia | 1.003 (1.000-1.005) | 0.027 | 1.003 (1.001–1.005) | 0.013 |
Agents induction anaesthesia | ||||
-Propofol -Other | 1 1.4 (0.6–3.1) | 0.435 | ||
Agents induction analgesia | ||||
-Sufentanil -Remifentanil -other | 1 0.4 (0-2.9) 0 (0) | 0.632 | ||
Agents maintenance anaesthesia | ||||
-Propofol -Isoflurane -Sevoflurane -Other | 1 1.2 (0.2–5.9) 0.6 (0.2–2.3) 0 (0) | 0.891 | ||
Agents maintenance analgesia | ||||
-Sufentanil -Remifentanil -Other | 1 1.3 (0.4–4.2) 0.4 (0–3.0) | 0.561 | ||
Additional vasoactive medication received | ||||
-No -Yes | 1 1.4 (0.2–11.1) | 0.776 | ||
Mean BIS | 1.0 (0.9–1.1) | 0.691 | ||
Mean BIS | ||||
-<45 ->=45 | 1 0.7 (0.2–2.3) | 0.551 | ||
BIS < 45 time | 1.0 (1.0–1.0) | 0.380 | ||
BIS < 45% | 1.0 (1.0–1.0) | 0.803 | ||
BIS > 60 time | 1.0 (1.0–1.0) | 0.729 | ||
BIS > 60% | 1.0 (0.9-1.0) | 0.536 | ||
MAP < 70 time | 1.0 (1.0–1.0) | 0.716 | ||
MAP 70 AUC | 1.0 (1.0–1.0) | 0.886 |